Literature DB >> 17641867

[New serum markers in prostate carcinoma and their application to artificial neural networks].

C Stephan1, K Jung, H Cammann, J Kramer, G Kristiansen, S A Loening, M Lein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17641867     DOI： 10.1007/s00120-007-1435-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  12 in total

1.  Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.

Authors:  Carsten Stephan; Moritz Klaas; Christian Müller; Dietmar Schnorr; Stefan A Loening; Klaus Jung
Journal:  Clin Chem       Date:  2006-01       Impact factor: 8.327

2.  Artificial neural networks: has the time come for their use in prostate cancer patients?

Authors:  Carsten Stephan; Henning Cammann; Klaus Jung
Journal:  Nat Clin Pract Urol       Date:  2005-06

3.  Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network.

Authors:  Carsten Stephan; Hellmuth-Alexander Meyer; Henning Cammann; Terukazu Nakamura; Eleftherios P Diamandis; Klaus Jung
Journal:  Biol Chem       Date:  2006-06       Impact factor: 3.915

4.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

5.  An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigation.

Authors:  Carsten Stephan; Klaus Jung; Henning Cammann; Birgit Vogel; Brigitte Brux; Glen Kristiansen; Birgit Rudolph; Steffen Hauptmann; Michael Lein; Dietmar Schnorr; Pranav Sinha; Stefan A Loening
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

6.  A (-5, -7) proPSA based artificial neural network to detect prostate cancer.

Authors:  Carsten Stephan; Hellmuth-Alexander Meyer; Maciej Kwiatkowski; Franz Recker; Henning Cammann; Stefan A Loening; Klaus Jung; Michael Lein
Journal:  Eur Urol       Date:  2006-05-02       Impact factor: 20.096

7.  Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network.

Authors:  P Finne; R Finne; A Auvinen; H Juusela; J Aro; L Määttänen; M Hakama; S Rannikko; T L Tammela; U Stenman
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

Review 8.  PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.

Authors:  Carsten Stephan; Henning Cammann; Hellmuth-A Meyer; Michael Lein; Klaus Jung
Journal:  Cancer Lett       Date:  2007-02-09       Impact factor: 8.679

9.  Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.

Authors:  Carsten Stephan; Klaus Jung; Antoninus Soosaipillai; George M Yousef; Henning Cammann; Hellmuth Meyer; Chuanliang Xu; Eleftherios P Diamandis
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

10.  Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

Authors:  Carsten Stephan; Henning Cammann; Axel Semjonow; Eleftherios P Diamandis; Leon F A Wymenga; Michael Lein; Pranav Sinha; Stefan A Loening; Klaus Jung
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.